This review focuses on the development of hyperglycemia arising from widely used cancer
therapies spanning four drug classes. These groups of medications were selected due to …

Purpose/Objectives: To review the literature regarding the development of hyperglycemia
associated with neoadjuvant agents used in the treatment of solid tumor cancers. Data …

A growing body of evidence supports hyperglycemia as a putative contributor to several
brain dysfunctions observed in diabetes patients, such as impaired memory capacity, neural …

Umbilical cord-derived mesenchymal stem cells (UC-MSCs) have been proved a promising
clinical strategy for the treatment of diabetes, and time in range (TIR) has been …

Hyperglycemia is a known complication of therapies used in the treatment of childhood
cancer, particularly glucocorticoids and asparaginase. It has been linked to increased …

Abstract Purpose of Review The purpose of this study is to describe the pathology, impact of
comorbidities, functional limitations, symptoms, and quality of life (QOL) related to treatment …

Background: Many people are still getting affected by uncontrolled glycemic events during
hospital admission, which encompasses hypoglycemia, hyperglycemia, and high glycemic …

Hyperglycemia, an elevation in blood glucose, is a major side-effect of cancer and cancer
treatment. In patients with cancer, hyperglycemia occurs frequently independent of the …

One of the dreaded life-threatening complications of diabetes mellitus (DM) is diabetic
ketoacidosis (DKA). American Diabetic Association (ADA) came out with 2018 guidelines on …

Objectives: To compare clinical outcomes and healthcare utilization in colorectal cancer
(CRC) survivors with and without diabetes. Sample & Setting: CRC survivors (N= 3,287) …